Luigi Ronga

Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives

Davide Fiore Bavaro, Alessandra Belati, Lucia Diella et al. · Antibiotics · 2021 · 92 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17

Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center Study

Lidia Dalfino, Monica Stufano, Davide Fiore Bavaro et al. · Antibiotics · 2023 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study

Davide Fiore Bavaro, Roberta Papagni, Alessandra Belati et al. · Infectious Diseases and Therapy · 2023 · 29 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +16

Epidemiological evaluation of human papillomavirus genotypes and their associations in multiple infections

Raffaele Del Prete, Luigi Ronga, Raffaella Magrone et al. · Epidemiology and Infection · 2019 · 26 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions

Valeria Cento, Massimo Ciccozzi, Luigi Ronga et al. · Journal of Medical Virology · 2009 · 25 citations · Full text

Medicine, Genetics, Molecular Genetics +17